Leukaemia-associated Rho guanine nucleotide exchange factor (LARG) plays an agonist specific role in platelet function through RhoA activation

 

 Buy Article Permissions and Reprints

Summary

Leukemia-Associated RhoGEF (LARG) is highly expressed in platelets, which are essential for maintaining normal haemostasis. We studied the function of LARG in murine and human megakaryocytes and platelets with Larg knockout (KO), shRNA-mediated knockdown and small molecule-mediated inhibition. We found that LARG is important for human, but not murine, megakaryocyte maturation. Larg KO mice exhibit macrothrombocytopenia, internal bleeding in the ovaries and prolonged bleeding times. KO platelets have impaired aggregation, α-granule release and integrin α2bβ3 activation in response to thrombin and thromboxane, but not to ADP. The same agonist-specific reductions in platelet aggregation occur in human platelets treated with a LARG inhibitor. Larg KO platelets have reduced RhoA activation and myosin light chain phosphorylation, suggesting that Larg plays an agonist-specific role in platelet signal transduction. Using two different in vivo assays, Larg KO mice are protected from in vivo thrombus formation. Together, these results establish that LARG regulates human megakaryocyte maturation, and is critical for platelet function in both humans and mice.

Supplementary Material to this article is available online at www.thrombosis-online.com.

• References

• 1 Rivera J, Lozano ML, Navarro-Nunez L. et al. Platelet receptors and signalling in the dynamics of thrombus formation. Haematologica 2009; 94: 700-711.
  CrossrefPubMedGoogle Scholar
• 2 Cabrera-Vera TM, Vanhauwe J, Thomas TO. et al. Insights into G protein structure, function, and regulation. Endocr Rev 2003; 24: 765-781.
  CrossrefPubMedGoogle Scholar
• 3 Li Z, Delaney MK, O’Brien KA. et al. Signalling during platelet adhesion and activation. Arterioscl Thromb Vasc Biol 2010; 30: 2341-2349.
  CrossrefPubMedGoogle Scholar
• 4 Aittaleb M, Boguth CA, Tesmer JJ.. Structure and function of heterotrimeric G protein-regulated Rho guanine nucleotide exchange factors. Mol Pharmacol 2010; 77: 111-125.
  CrossrefPubMedGoogle Scholar
• 5 Jin J, Kunapuli SP.. Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation. Proc Natl Acad Sci USA 1998; 95: 8070-8074.
  CrossrefPubMedGoogle Scholar
• 6 Siderovski DP, Willard FS.. The GAPs, GEFs, and GDIs of heterotrimeric G-protein alpha subunits. Int J Biol Sci 2005; 1: 51-66.
  PubMedGoogle Scholar
• 7 Kourlas PJ, Strout MP, Becknell B. et al. Identification of a gene at 11q23 encoding a guanine nucleotide exchange factor: evidence for its fusion with MLL in acute myeloid leukemia. Proc Natl Acad Sci USA 2000; 97: 2145-2150.
  CrossrefPubMedGoogle Scholar
• 8 Simon LM, Edelstein LC, Nagalla S. et al. Human platelet microRNA-mRNA networks associated with age and gender revealed by integrated plateletomics. Blood 2014; 123: e37-45.
  CrossrefPubMedGoogle Scholar
• 9 Mikelis CM, Palmby TR, Simaan M. et al. PDZ- Rho GEF and LARG are essential for embryonic development and provide a link between thrombin and LPA receptors and Rho activation. J Biol Chem 2013; 288: 12232-12243.
  CrossrefPubMedGoogle Scholar
• 10 Brass LF.. Thrombin and platelet activation. Chest 2003; 124: 18S-25S.
  CrossrefPubMedGoogle Scholar
• 11 Pronk CJ, Rossi DJ, Mansson R. et al. Elucidation of the phenotypic, functional, and molecular topography of a myeloerythroid progenitor cell hierarchy. Cell Stem Cell 2007; 1: 428-442.
  CrossrefPubMedGoogle Scholar
• 12 Godin D, Ivan E, Johnson C. et al. Remodeling of Carotid Artery Is Associated With Increased Expression of Matrix Metalloproteinases in Mouse Blood Flow Cessation Model. Circulation 2000; 102: 2861-2866.
  CrossrefPubMedGoogle Scholar
• 13 Tang WH, Stitham J, Jin Y. et al. Aldose reductase-mediated phosphorylation of p53 leads to mitochondrial dysfunction and damage in diabetic platelets. Circulation 2014; 129: 1598-1609.
  CrossrefPubMedGoogle Scholar
• 14 Owens 3rd AP, Lu Y, Whinna HC. et al. Towards a standardisation of the murine ferric chloride-induced carotid arterial thrombosis model. J Thromb Haemost 2011; 9: 1862-1863.
  CrossrefPubMedGoogle Scholar
• 15 Moers A, Wettschureck N, Gruner S. et al. Unresponsiveness of platelets lacking both Galpha(q) and Galpha(13). Implications for collagen-induced platelet activation. J Biol Chem 2004; 279: 45354-45359.
  CrossrefPubMedGoogle Scholar
• 16 Nieswandt B, Schulte V, Zywietz A. et al. Costimulation of Gi- and G12/G13-mediated signalling pathways induces integrin alpha IIbbeta 3 activation in platelets. J Biol Chem 2002; 277: 39493-39498.
  CrossrefPubMedGoogle Scholar
• 17 Coughlin SR.. Protease-activated receptors in haemostasis, thrombosis and vascular biology. J Thromb Haemost 2005; 3: 1800-1814.
  CrossrefPubMedGoogle Scholar
• 18 Shang X, Marchioni F, Evelyn CR. et al. Small-molecule inhibitors targeting G-protein-coupled Rho guanine nucleotide exchange factors. Proc Natl Acad Sci USA 2013; 110: 3155-3160.
  CrossrefPubMedGoogle Scholar
• 19 Williams CM, Harper MT, Goggs R. et al. Leukemia-associated Rho guanine-nucleotide exchange factor is not critical for RhoA regulation, yet is important for platelet activation and thrombosis in mice. J Thromb Haemost. 2015 Epub ahead of print.
  PubMedGoogle Scholar
• 20 Stojanovic A, Marjanovic JA, Brovkovych VM. et al. A phosphoinositide 3-kinase-AKT-nitric oxide-cGMP signalling pathway in stimulating platelet secretion and aggregation. J Biol Chem 2006; 281: 16333-16339.
  CrossrefPubMedGoogle Scholar
• 21 Woulfe D, Jiang H, Morgans A. et al. Defects in secretion, aggregation, and thrombus formation in platelets from mice lacking Akt2. J Clin Invest 2004; 113: 441-450.
  CrossrefPubMedGoogle Scholar
• 22 Medlin MD, Staus DP, Dubash AD. et al. Sphingosine 1-phosphate receptor 2 signals through leukemia-associated RhoGEF (LARG), to promote smooth muscle cell differentiation. Arterioscl Thromb Vasc Biol 2010; 30: 1779-1786.
  CrossrefPubMedGoogle Scholar
• 23 Ying Z, Jin L, Palmer T. et al. Angiotensin II up-regulates the leukemia-associated Rho guanine nucleotide exchange factor (RhoGEF), a regulator of G protein signalling domain-containing RhoGEF, in vascular smooth muscle cells. Mol Pharmacol 2006; 69: 932-940.
  PubMedGoogle Scholar
• 24 Kiel MJ, Yilmaz OH, Iwashita T. et al. SLAM family receptors distinguish haematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 2005; 121: 1109-1121.
  CrossrefPubMedGoogle Scholar
• 25 Osawa M, Hanada K, Hamada H. et al. Long-term lymphohaematopoietic reconstitution by a single CD34-low/negative haematopoietic stem cell. Science 1996; 273: 242-245.
  CrossrefPubMedGoogle Scholar
• 26 Sitnicka E, Buza-Vidas N, Larsson S. et al. Human CD34+ haematopoietic stem cells capable of multilineage engrafting NOD/SCID mice express flt3: distinct flt3 and c-kit expression and response patterns on mouse and candidate human haematopoietic stem cells. Blood 2003; 102: 881-886.
  CrossrefPubMedGoogle Scholar
• 27 Larochelle A, Savona M, Wiggins M. et al. Human and rhesus macaque haematopoietic stem cells cannot be purified based only on SLAM family markers. Blood 2011; 117: 1550-1554.
  CrossrefPubMedGoogle Scholar
• 28 Antonchuk J, Sauvageau G, Humphries RK.. HOXB4-induced expansion of adult haematopoietic stem cells ex vivo. Cell 2002; 109: 39-45.
  CrossrefPubMedGoogle Scholar
• 29 Amsellem S, Pflumio F, Bardinet D. et al. Ex vivo expansion of human haematopoietic stem cells by direct delivery of the HOXB4 homeoprotein. Nat Med 2003; 9: 1423-1427.
  CrossrefPubMedGoogle Scholar
• 30 Wang L, Menendez P, Shojaei F. et al. Generation of haematopoietic repopulating cells from human embryonic stem cells independent of ectopic HOXB4 expression. J Exp Med 2005; 201: 1603-1614.
  CrossrefPubMedGoogle Scholar
• 31 Iwasaki H, Akashi K.. Haematopoietic developmental pathways: on cellular basis. Oncogene 2007; 26: 6687-6696.
  CrossrefPubMedGoogle Scholar
• 32 Parekh C, Crooks GM.. Critical differences in haematopoiesis and lymphoid development between humans and mice. J Clin Immunol 2013; 33: 711-715.
  CrossrefPubMedGoogle Scholar
• 33 Terzic M, Likic I, Pilic I. et al. Conservative management of massive haematoperitoneum caused by ovulation in a patient with severe form of von Willebrand disease--a case report. Clin Exp Obstet Gynecol 2012; 39: 537-540.
  PubMedGoogle Scholar
• 34 Gupta A, Gupta S, Manaktala U. et al. Conservative management of corpus luteum haemorrhage in patients on anticoagulation: a report of three cases and review of literature. Arch Gynecol Obstet 2015; 291: 427-431.
  CrossrefPubMedGoogle Scholar
• 35 Guthikonda S, Alviar CL, Vaduganathan M. et al. Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease. J Am Coll Cardiol 2008; 52: 743-749.
  CrossrefPubMedGoogle Scholar
• 36 Chiu WC, Juang JM, Chang SN. et al. Angiotensin II regulates the LARG/RhoA/ MYPT1 axis in rat vascular smooth muscle in vitro. Acta Pharmacol Sin 2012; 33: 1502-1510.
  CrossrefPubMedGoogle Scholar
• 37 Booden MA, Siderovski DP, Der CJ.. Leukemia-associated Rho guanine nucleotide exchange factor promotes G alpha q-coupled activation of RhoA. Mol Cell Biol 2002; 22: 4053-4061.
  CrossrefPubMedGoogle Scholar
• 38 Gachet C.. P2 receptors, platelet function and pharmacological implications. Thromb Haemost 2008; 99: 466-472.
  Article in Thieme ConnectPubMedGoogle Scholar
• 39 Moers A, Nieswandt B, Massberg S. et al. G13 is an essential mediator of platelet activation in haemostasis and thrombosis. Nat Med 2003; 9: 1418-1422.
  CrossrefPubMedGoogle Scholar
• 40 Pleines I, Hagedorn I, Gupta S. et al. Megakaryocyte-specific RhoA deficiency causes macrothrombocytopenia and defective platelet activation in haemostasis and thrombosis. Blood 2012; 119: 1054-1063.
  CrossrefPubMedGoogle Scholar
• 41 Pfreimer M, Vatter P, Langer T. et al. LARG links histamine-H1-receptor-activated Gq to Rho-GTPase-dependent signalling pathways. Cell Signal 2012; 24: 652-663.
  CrossrefPubMedGoogle Scholar
• 42 Offermanns S, Toombs CF, Hu YH. et al. Defective platelet activation in G alpha(q)-deficient mice. Nature 1997; 389: 183-186.
  CrossrefPubMedGoogle Scholar
• 43 Rossman KL, Der CJ, Sondek J.. GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors. Nat Rev Mol Cell Biol 2005; 6: 167-180.
  CrossrefPubMedGoogle Scholar
• 44 Huang JS, Dong L, Kozasa T. et al. Signalling through G(alpha)13 switch region I is essential for protease-activated receptor 1-mediated human platelet shape change, aggregation, and secretion. J Biol Chem 2007; 282: 10210-10222.
  CrossrefPubMedGoogle Scholar
• 45 Aslan JE, Baker SM, Loren CP. et al. The PAK system links Rho GTPase signalling to thrombin-mediated platelet activation. Am J Physiol Cell Physiol 2013; 305: C519-528.
  CrossrefPubMedGoogle Scholar
• 46 Jin J, Mao Y, Thomas D. et al. RhoA downstream of G(q) and G(12/13) pathways regulates protease-activated receptor-mediated dense granule release in platelets. Biochem Pharmacol 2009; 77: 835-844.
  CrossrefPubMedGoogle Scholar
• 47 Goggs R, Williams CM, Mellor H. et al. Platelet Rho GTPases-a focus on novel players, roles and relationships. Biochem J 2015; 466: 431-442.
  CrossrefPubMedGoogle Scholar

• Supplementary Material